ADRXVSCRL• 28 Days (Normalized)
ADRX vs CRL (ADARx Pharmaceuticals Inc. vs Charles River Laboratories International Inc.)
Showing Closing Date Range from Sep 9 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ADRX Performance $18.58
-3.98%
ADARx Pharmaceuticals Inc.
Normalized Baseline0.00%
CRL Performance $304.96
+9.56%
Charles River Laboratories International Inc.
Normalized Baseline0.00%
Alpha Spread Margin CRL LEADS
-13.54 pts
CRL outperforming by 13.54 percentage points
ADRXCRL
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ADRX CRL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | ADRX Price | ADRX Gain (%) | CRL Price | CRL Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $18.58 | -3.98% | $304.96 | +9.56% | -13.54% |
| Oct 05, 2026 | $19.05 | -1.55% | $310.77 | +11.65% | -13.20% |
| Oct 02, 2026 | $18.25 | -5.68% | $290.19 | +4.25% | -9.93% |
| Oct 01, 2026 | $- | $286.83 | +3.05% | - | |
| Sep 30, 2026 | $- | $295.01 | +5.99% | - | |
| Sep 29, 2026 | $20.64 | +6.67% | $295.96 | +6.33% | +0.34% |
| Sep 28, 2026 | $20.09 | +3.82% | $294.59 | +5.83% | -2.01% |
| Sep 25, 2026 | $19.35 | +0.00% | $292.84 | +5.21% | -5.21% |
| Sep 23, 2026 | $- | $277.33 | -0.37% | - | |
| Sep 22, 2026 | $- | $285.11 | +2.43% | - | |
| Sep 21, 2026 | $- | $279.01 | +0.24% | - | |
| Sep 18, 2026 | $- | $278.06 | -0.10% | - | |
| Sep 17, 2026 | $- | $281.67 | +1.19% | - | |
| Sep 16, 2026 | $- | $273.41 | -1.77% | - | |
| Sep 15, 2026 | $- | $272.88 | -1.97% | - |
Page 1 of 2